NCT07012447: Venetoclax + Azacytidine for Newly Diagnosed ETP-like ALL and T-ALL With Myeloid Mutations
- State
- Under way
- Phase
- Phase 2
- People
- 32 planned
- Started
- 1 Apr 2025
- Primary completion
- 1 Apr 2027
- Arms
- Investigational ( venetoclax, azacytidine)
- Results
- None posted
- 1 Apr 2025: Trial started
- 10 Jun 2025: Trial registered